Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiorica

Showing results (321-330 of 349) with videos related to

Pageof 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2018
Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian CancerNicoletta Colombo, Gloria Huang, Giovanni Scambia, et al.
Cancers|July 27, 2022
Inflammatory Microenvironment in Early Non-Small Cell Lung Cancer: Exploring the Predictive Value of RadiomicsMariasole Perrone, Edoardo Raimondi, Matilde Costa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 13, 2004
Lysophospholipids are potential biomarkers of ovarian cancerRebecca Sutphen, Yan Xu, George D Wilbanks, et al.
Gynecologic Oncology|December 4, 2019
A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancerIgnace Vergote, Florian Heitz, Paul Buderath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183Hedvig Hricak, Constantine Gatsonis, Dennis S Chi, et al.
Cureus|September 13, 2021
Effectiveness of COVID-19 Convalescent Plasma Infusion Within 48 Hours of Hospitalization With SARS-CoV-2 InfectionNatalia Lattanzio, Cristina Acosta-Diaz, Ricardo J Villasmil, et al.
Cell Death and Differentiation|November 30, 2022
PML at mitochondria-associated membranes governs a trimeric complex with NLRP3 and P2X7R that modulates the tumor immune microenvironmentSonia Missiroli, Mariasole Perrone, Roberta Gafà, et al.
International Journal of Molecular Sciences|August 28, 2025
Investigating the Impact of <i>Fusobacterium nucleatum</i> on Oxidative Stress, Chemoresistance, and Inflammation in Inflammatory Bowel Disease and Colorectal Cancer: Rationale and Design of a Clinical TrialPierluigi Consolo, Carlotta Giorgi, Concetta Crisafulli, et al.
British Journal of Cancer|October 8, 2014
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumoursI Brana, R Berger, T Golan, et al.
Plos One|March 16, 2021
Psychological impact of Covid-19 pandemic on oncological patients: A survey in Northern ItalyEva Pigozzi, Daniela Tregnago, Lucia Costa, et al.
Pageof 35

Showing results (321-330 of 349) with videos related to

Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2018
Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian CancerNicoletta Colombo, Gloria Huang, Giovanni Scambia, et al.
Cancers|July 27, 2022
Inflammatory Microenvironment in Early Non-Small Cell Lung Cancer: Exploring the Predictive Value of RadiomicsMariasole Perrone, Edoardo Raimondi, Matilde Costa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 13, 2004
Lysophospholipids are potential biomarkers of ovarian cancerRebecca Sutphen, Yan Xu, George D Wilbanks, et al.
Gynecologic Oncology|December 4, 2019
A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancerIgnace Vergote, Florian Heitz, Paul Buderath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183Hedvig Hricak, Constantine Gatsonis, Dennis S Chi, et al.
Cureus|September 13, 2021
Effectiveness of COVID-19 Convalescent Plasma Infusion Within 48 Hours of Hospitalization With SARS-CoV-2 InfectionNatalia Lattanzio, Cristina Acosta-Diaz, Ricardo J Villasmil, et al.
Cell Death and Differentiation|November 30, 2022
PML at mitochondria-associated membranes governs a trimeric complex with NLRP3 and P2X7R that modulates the tumor immune microenvironmentSonia Missiroli, Mariasole Perrone, Roberta Gafà, et al.
International Journal of Molecular Sciences|August 28, 2025
Investigating the Impact of <i>Fusobacterium nucleatum</i> on Oxidative Stress, Chemoresistance, and Inflammation in Inflammatory Bowel Disease and Colorectal Cancer: Rationale and Design of a Clinical TrialPierluigi Consolo, Carlotta Giorgi, Concetta Crisafulli, et al.
British Journal of Cancer|October 8, 2014
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumoursI Brana, R Berger, T Golan, et al.
Plos One|March 16, 2021
Psychological impact of Covid-19 pandemic on oncological patients: A survey in Northern ItalyEva Pigozzi, Daniela Tregnago, Lucia Costa, et al.
Pageof 35